help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 27, 2005
Endocrinology, doi:10.1210/en.2004-1366
A more recent version of this article appeared on May 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/5/2210    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Puga, I.
Right arrow Articles by Espel, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puga, I.
Right arrow Articles by Espel, E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DACTINOMYCIN

Submitted on October 18, 2004
Accepted on January 18, 2005

A POLYMORPHISM IN THE 3' UNTRANSLATED REGION OF THE GENE FOR TUMOR NECROSIS FACTOR RECEPTOR 2 (TNFR2) MODULATES REPORTER GENE EXPRESSION

Irene Puga, Begoña Lainez, José Manuel Fernández-Real, Maria Buxadé, Montserrat Broch, Joan Vendrell, and Enric Espel*

Departament de Fisiologia, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, E-08028 Barcelona, Spain; Diabetes, Endocrinology and Nutrition Research Unit, University of Girona, Hospital of Girona "Dr Josep Trueta", Carretera de Francia s/n, E-17007 Girona, Spain; Universitat Rovira-Virgili, Tarragona, Spain

* To whom correspondence should be addressed. E-mail: eespel{at}ub.edu.

The gene encoding the human tumor necrosis factor- receptor (TNFR) 2 contains polymorphisms in the 3' untranslated region (UTR). Previous studies have shown that some variant alleles in this region are associated with obesity and insulin resistance. However, the effect of these polymorphisms on the expression of TNFR2 has not been studied to date. To examine the role played by different haplotypes in the control of TNFR2 expression (haplotypes A1-A5, referring to nucleotides 1663 G/A, 1668 T/G and 1690 T/C), we introduced these sequences into the 3'-UTR of a heterologous reporter gene and expressed the corresponding constructs in a human T cell line. We demonstrate that a 485 nt fragment of the TNFR2 3'-UTR that contains a U-rich region decreases reporter expression, and that haplotypes A1-A4 exert a stronger effect than A5. Furthermore, time-course assays of mRNA stability using actinomycin D revealed that haplotypes A1-A4 destabilize the mRNA. The proximal TNFR2 3'-UTR, independently of haplotype differences, responded to T-cell activation by increasing mRNA decay. Electromobility shift analysis demonstrated that protein(s) found in T cell extracts bind to the 485 nt fragment. We suggest that an increased rate of TNFR2 mRNA decay protects cells from unrestrained TNF- effects, and that this protection is weakened in A5 subjects. These findings may explain the association of this haplotype with obesity and increased leptin levels.


Key words: TNFR2 • 3'-UTR • polymorphism • mRNA stability • ARE




This article has been cited by other articles:


Home page
ScienceHome page
A. G. Nackley, S. A. Shabalina, I. E. Tchivileva, K. Satterfield, O. Korchynskyi, S. S. Makarov, W. Maixner, and L. Diatchenko
Human Catechol-O-Methyltransferase Haplotypes Modulate Protein Expression by Altering mRNA Secondary Structure
Science, December 22, 2006; 314(5807): 1930 - 1933.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society